- 
                        IntroducedNov 30, 2021
- 
                        Passed Senate
- 
                        Passed House
- 
                        Signed into Law
                    
                    
                    Regulation of Compounded Drug Products; Requiring the Surgeon General, on behalf of the Department of Health, to sign and become a party to the United States Food and Drug Administration’s Memorandum of Understanding Addressing Certain Distributions of Compounded Human Drug Products; requiring certain pharmacy permittees to annually report information to the National Association of Boards of Pharmacy’s information sharing network as required by the memorandum, etc.
                
                
            
        Last Action See all actions
                         Senate • Mar 14, 2022: Died in Health Policy
Latest Bill Text See all bill texts
                        
                        
                        
            Summary/Bill Text
Comments on SB 1096
Tweets
Whip Lists
Sponsors
                - Brodeurprimary
Votes
                        
  
       Actions
            - Mar 14, 2022 | Senate- Died in Health Policy
 
- Mar 12, 2022 | Senate- Indefinitely postponed and withdrawn from consideration
 
- Jan 11, 2022 | Senate- Introduced
 
- Dec 13, 2021 | Senate- Referred to Health Policy; Regulated Industries; Rules
 
- Nov 30, 2021 | Senate- Filed
 
Bill Texts 
        
            
    Documents
        
            
 Report a comment
 Report a comment